Risks of noncardiac surgery early after percutaneous coronary intervention

被引:16
|
作者
Smilowitz, Nathaniel R. [1 ,2 ]
Lorin, Jeffrey [1 ,2 ]
Berger, Jeffrey S. [1 ,3 ]
机构
[1] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY USA
[2] Vet Affairs New York Harbor Hlth Care Syst, Dept Med, Div Cardiol, New York, NY USA
[3] NYU, Sch Med, Dept Surg, New York, NY USA
基金
美国国家卫生研究院;
关键词
DRUG-ELUTING STENTS; ADVERSE CARDIAC EVENTS; PERIOPERATIVE MANAGEMENT; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; CARDIOVASCULAR RISK; 30-DAY MORTALITY; TROPONIN LEVELS; ASSOCIATION; REVASCULARIZATION;
D O I
10.1016/j.ahj.2019.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Prior registry data suggest that 4%-20% of patients require noncardiac surgery (NCS) within 2 years of percutaneous coronary intervention (PCI). Contemporary data on NCS after PCI in the United States among women and men are limited. We determined the rate of early hospital readmission for NCS and associated outcomes in a large cohort of patients who underwent PCI in the United States. Methods Adults undergoing PCI between January 1 and June 30, 2014, were identified from the Nationwide Readmission Database. Patients readmitted for NCS within 6 months of PCI were identified. Outcomes of interest were inhospital death, myocardial infarction (MI), and bleeding defined by international Classification of Diseases, Ninth Revision, codes. Results Among 221,379 patients who underwent PCI and survived to hospital discharge, 3.5% (n = 7,696) were readmitted for NCS within 6 months post-PCI, and 41% of these hospitalizations were elective. Early NCS was complicated by MI in 4.7% of cases, and 21% of perioperative MIs were fatal. Bleeding was recorded in 32.0% of patients. All-cause mortality occurred in 4.4% of patients (n = 339) readmitted for surgery. The risk of death or MI was greatest when NCS was performed within the first month after PCI. Conclusions Despite clear guidelines to avoid surgery early after PCI, NCS was performed in 1 of every 29 patients with recent PCI, corresponding to as many as similar to 30,000 patients each year nationwide. Surgical mortality and perioperative MI were high in this setting. Strategies to minimize perioperative thrombotic and bleeding risks during readmission for NCS after PCI are necessary.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 50 条
  • [41] Atrial fibrillation incidence after coronary artery bypass graft surgery and percutaneous coronary intervention: the prospective AFAF cohort study
    Wickbom, Anders
    Fengsrud, Espen
    Alfredsson, Joakim
    Engdahl, Johan
    Kalm, Torbjoern
    Ahlsson, Anders
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2024, 58 (01)
  • [42] The Risk of Adverse Cardiac and Bleeding Events Following Noncardiac Surgery Relative to Antiplatelet Therapy in Patients With Prior Percutaneous Coronary Intervention
    Singla, Sandeep
    Sachdeva, Rajesh
    Uretsky, Barry F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (20) : 2005 - 2016
  • [43] Ticagrelor With or Without Aspirin After Complex Percutaneous Coronary Intervention
    Dangas, George
    Baber, Usman
    Sharma, Samin
    Giustino, Gennaro
    Mehta, Shamir
    Cohen, David J.
    Angiolillo, Dominick J.
    Sartori, Samantha
    Chandiramani, Rishi
    Briguori, Carlo
    Dudek, Dariusz
    Escaned, Javier
    Huber, Kurt
    Collier, Timothy
    Kornowski, Ran
    Kunadian, Vijay
    Kaul, Upendra
    Oldroyd, Keith
    Sardella, Gennaro
    Shlofmitz, Richard
    Witzenbichler, Bernhard
    Han Ya-Ling
    Pocock, Stuart
    Gibson, C. Michael
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (19) : 2414 - 2424
  • [44] Follow-up strategies and individual risk profile after percutaneous coronary intervention: The prospective post percutaneous coronary intervention registry
    Ferlini, Marco
    Musumeci, Giuseppe
    Grieco, Niccolo
    Trabattoni, Daniela
    Castiglioni, Battistina
    Lettieri, Corrado
    Klersy, Catherine
    Tarantini, Giuseppe
    Visconti, Luigi Oltrona
    Rossini, Roberta
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 (02) : E209 - E218
  • [45] Coronary angiography and percutaneous intervention after resuscitation
    Rudas Laszlo
    Zima Endre
    ORVOSI HETILAP, 2019, 160 (46) : 1826 - 1831
  • [46] Frailty and Bleeding After Percutaneous Coronary Intervention
    Kanenawa, Kenji
    Yamaji, Kyohei
    Tashiro, Hiroaki
    Morimoto, Takeshi
    Hiromasa, Takashi
    Hayashi, Masaomi
    Hiramori, Seiichi
    Tomoi, Yusuke
    Kuramitsu, Shoichi
    Domei, Takenori
    Hyodo, Makoto
    Ando, Kenji
    Kimura, Takeshi
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 148 : 22 - 29
  • [47] Pulmonary Hemorrhage after Percutaneous Coronary Intervention
    Yan, Yuan-Horng
    Chen, Cheng-Yun
    Chen, Cheng-Ren
    Hsu, Chen-Tung
    ACTA CARDIOLOGICA SINICA, 2010, 26 (01) : 37 - 40
  • [48] Antiplatelet Therapy After Percutaneous Coronary Intervention
    Natsuaki, Masahiro
    Kimura, Takeshi
    CIRCULATION JOURNAL, 2022, 86 (05) : 741 - 747
  • [49] Insights into myocardial infarction after noncardiac surgery in patients with a prior coronary artery stent
    Devereaux, P. J.
    Eikelboom, J.
    BRITISH JOURNAL OF ANAESTHESIA, 2016, 116 (05) : 584 - 586
  • [50] Survival difference between coronary bypass surgery and percutaneous coronary intervention
    Molstad, Per
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2015, 49 (04) : 177 - 182